Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
623,028
+77,599
+14% +$190K ﹤0.01% 3731
2026
Q1
$1.74M Buy
545,429
+497,913
+1,048% +$906K ﹤0.01% 3021
2025
Q4
$66K Sell
47,516
-152,391
-76% -$307K ﹤0.01% 4422
2025
Q3
$450K Buy
+199,907
New +$531K ﹤0.01% 3913
2024
Q4
Sell
-14,263
Closed -$32.8K 4382
2024
Q3
$32.8K Buy
14,263
+2,100
+17% +$5.89K ﹤0.01% 4318
2024
Q2
$36.6K Buy
+12,163
New +$46.4K ﹤0.01% 4233
2024
Q1
Sell
-88,714
Closed -$465K 4319
2023
Q4
$465K Buy
88,714
+26,107
+42% +$123K ﹤0.01% 3544
2023
Q3
$260K Buy
+62,607
New +$383K ﹤0.01% 3673
2022
Q1
Sell
-78,937
Closed -$971K 5497
2021
Q4
$971K Buy
+78,937
New +$1.39M ﹤0.01% 3948

Other funds holding AMTX

David Shaw's AMTX Position: Q2 2026 in Review

David Shaw increased its Aemetis (AMTX) stake by 14% in Q2 2026, buying an estimated $190K and bringing the position to 623,028 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3731.

David Shaw first reported a position in AMTX in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.74M in Q1 2026. 88 funds tracked by Wall St. Rank hold AMTX as of Q2 2026.

  • David Shaw held 623,028 shares of Aemetis worth $1.02M as of Q2 2026.
  • David Shaw bought 77,599 Aemetis shares in Q2 2026, an estimated $190K.
  • Aemetis made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3731 holding.
  • David Shaw first reported a position in Aemetis in Q4 2021 and has held it in 9 quarters since.
  • David Shaw's Aemetis position peaked at $1.74M in Q1 2026.
  • 88 funds tracked by Wall St. Rank held Aemetis as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.